Collections
Open for Submissions
Cancer therapy: KRAS targeted therapies
Guest Editors:
Biswarup Saha, MS, MTech, PhD, H Lee Moffitt Cancer Center & Research Institute, USA
Hitendra Singh Solanki, PhD, H. Lee Moffitt Cancer Center, USA
Submission Status: Open until 21 November 2024
Hyperthermia therapy for cancer
Guest Editors:
Arlene Oei, PhD, Amsterdam University Medical Center, The Netherlands
Tan Hwei Ching Grace, MBBS, MRCS, MMED, FRCS, Melissa Teo Surgery and The Surgical Oncology Clinic, Singapore
Submission Status: Open until 8 November 2024
Rare cancers
Guest Editors:
Atif A. Ahmed, MD, University of Washington, Seattle Children’s Hospital, United States
Bruna Samia Dalmasso, MD, PhD, Genetics of Rare Cancers, IRCCS Ospedale Policlinico San Martino, Italy
Submission Status: Open until 6 September 2024
Viral carcinogenesis
Guest Editor:
Julian Naipauer, PhD, Instituto de FisiologÃa, BiologÃa Molecular y Neurociencias, Argentina
Submission Status: Open until 20 August 2024
Altered DNA repair mechanism in tumorigenesis
Guest Editors:
Kiyohiro Ando, MD, PhD, Saitama Cancer Center, Research Institute for Clinical Oncology, Japan
Pietro Di Fazio, PhD, Department of Visceral, Thoracic and Vascular Surgery, Philipps University Marburg, Germany
Zhihua Kang, PhD, Rutgers Cancer Institute of New Jersey, United States
Submission Status: Open until 20 July 2024
Applications of ctDNA and liquid biopsies in precision oncology
Guest Editors:
Claude Chelala, PhD, Queen Mary University of London, UK
Pasquale Pisapia, PhD, University of Naples Federico II, Italy
Submission Status: Open until 24 July 2024
Overcoming therapy resistance in prostate cancer
Guest Editors:
Holger Erb: Dresden University of Technology, Germany
Jacob Orme: Mayo Clinic, US
Submission Status: Open until 19 July 2024
Radiomics in cancer diagnosis and treatment
Guest Editors:
Archya Dasgupta: Tata Memorial Centre, Homi Bhabha National Institute, India
Qingtao Qiu: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, China
Stefania Volpe: European Institute of Oncology (Istituto Europeo di Oncologia, IEO) IRCCS and University of Milan, Italy
Submission Status: Open until 17 July 2024
Cancer stem cells in the tumor microenvironment
Guest Editors:
Liang Qiao: Westmead Institute for Medical Research and The University of Sydney, Australia
Jenny Y. Wang: University of Sydney and Kolling Institute, Australia
Submission Status: Open until 9 July 2024
Diet and physical activity during and after cancer treatment
Guest Editors:
Nicolas H. Hart: University of Technology Sydney, Australia
Dominic O’Connor: University of Nottingham, United Kingdom
Submission Status: Open until 18 June 2024
Immunology and immunotherapy in solid cancers
Guest Editors:
Zachary C. Hartman: Duke University, United States
Daniel Smrz: Charles University and Motol University Hospital, Czech Republic
Submission Status: Open until 29 May 2024
Advances in personalized radiotherapy
Guest Editors:
Venkata SK. Manem: University of Quebec at Trois-Rivières, Canada
Farzad Taghizadeh-Hesary: Iran University of Medical Sciences, Iran
Submission Status: Open until 29 March 2024
Published
New breakthroughs and future directions in the treatment of hematological malignancies
Guest Editors:
Ajay Abraham: Northwestern University, United States
Ahmet Emre EÅŸkazan: Istanbul University-CerrahpaÅŸa, Turkey
Cancer metabolism
Guest Editors:
Elavarasan Subramani: The University of Texas M.D. Anderson Cancer Center, United States
Marija Traikovic-Arsic: German Cancer Consortium, Germany
Cancer control in low- and middle-income countries
Guest Editors:
Cristina Stefan: Institute of Global Health Equity Research, Rwanda
Shenglan Tang: Duke University, United States
Advances in pre-clinical cancer models
Guest Editors:
Ryan C. Fields: Washington University School of Medicine in St. Louis, USA
Anna Golebiewska: Luxembourg Institute of Health, Luxembourg
Extracellular vesicles in cancer progression
Guest Editors:
Orazio Fortunato: Tumor Genomic Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy
Irina Matei: Weill Cornell Medicine, USA
Chunlin Ou: Xiangya Hospital, Central South University, China
Microbiome and cancer - Cross journal collection
Guest editors: Prof. Christopher Staley, Dr. Jacques Ravel and Dr. Sean Devlin.
Targeted therapies - Cross journal collection
Guest Editors: Prof. Min Li and Dr. Yanis Boumber
Advances in CAR-T immunotherapy - Cross journal collection
Guest Editors: Profs Marko Radic, Djordje Atanackovic and Tim Luetkens
2016
Cross journal collection
Translational Oncology
Guest editor: Prof Tommaso Dragani
Collection published: 28 July 2016
2014
Cross journal collection
Roles of microRNAs and other noncoding RNAs in cancer
Collection published: 26 November 2014
2012
Cross journal collection
Cancer bioinformatics: bioinformatic methods, network biomarkers and precision medicine
Edited by: Xiangdong Wang
Collection published: 1 May 2012
2011
Thematic series
BMC Cancer's 10th anniversary special edition
BMC Cancer
Collection published: 30 November 2011
Annual Journal Metrics
-
2022 Citation Impact
3.8 - 2-year Impact Factor
4.3 - 5-year Impact Factor
1.166 - SNIP (Source Normalized Impact per Paper)
1.137 - SJR (SCImago Journal Rank)2023 Speed
30 days submission to first editorial decision for all manuscripts (Median)
150 days submission to accept (Median)2023 Usage
7,974,312 downloads
3,975 Altmetric mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication